Spliceostatins and thailanstatins are intriguing natural products due to their structural features as well as their biological significance. This family of natural products has been the subject of immense synthetic interest because they exhibit very potent cytotoxicity in representative human cancer cell lines. The cytotoxic properties of these natural products are related to their ability to inhibit spliceosomes. FR901564 and spliceostatins have been shown to inhibit spliceosomes by binding to their SF3B component. Structurally, these natural products contain two highly functionalized tetrahydropyran rings with multiple stereogenic centers joined by a diene moiety and an acyclic side chain linked with an amide bond. Total syntheses of this...
Spliceostatin A is a potent inhibitor of spliceosomes and exhibits excellent anticancer activity aga...
Spliceostatin A is a potent inhibitor of spliceosomes and exhibits excellent anticancer activity aga...
Targeting the spliceosome with small molecule inhibitors provides a new avenue to target cancer by i...
ABSTRACT: FR901464 (1) and spliceostatin A (2) are potent inhibitors of spliceosomes. These compound...
FR901464 (1) and spliceostatin A (2) are potent inhibitors of spliceosomes. These compounds have sho...
FR901464 (<b>1</b>) and spliceostatin A (<b>2</b>) are potent inhibitors of spliceosomes. These comp...
The first stereoselective total synthesis of spliceostatin E has been accomplished. The left hand δ-...
Enantioselective syntheses of FR901464 and spliceostatin A, potent spliceosome inhibitors, are descr...
Efficient and selective total syntheses of spliceosome modulating natural products thailanstatins A...
ABSTRACT: An enantioselective total synthesis of spliceostatin E has been accomplished. The δ-lacton...
An enantioselective total synthesis of spliceostatin E has been accomplished. The δ-lactone unit A w...
Small molecule inhibitors that target components of the spliceosome have great potential as tools to...
An enantioselective total synthesis of spliceostatin E has been accomplished. The δ-lactone unit A w...
The spliceosome is a dynamic ribonucleo-protein complex that is in charge of removing introns from p...
Mining the genome sequence of <i>Burkholderia thailandensis</i> MSMB43 revealed a cryptic biosynthet...
Spliceostatin A is a potent inhibitor of spliceosomes and exhibits excellent anticancer activity aga...
Spliceostatin A is a potent inhibitor of spliceosomes and exhibits excellent anticancer activity aga...
Targeting the spliceosome with small molecule inhibitors provides a new avenue to target cancer by i...
ABSTRACT: FR901464 (1) and spliceostatin A (2) are potent inhibitors of spliceosomes. These compound...
FR901464 (1) and spliceostatin A (2) are potent inhibitors of spliceosomes. These compounds have sho...
FR901464 (<b>1</b>) and spliceostatin A (<b>2</b>) are potent inhibitors of spliceosomes. These comp...
The first stereoselective total synthesis of spliceostatin E has been accomplished. The left hand δ-...
Enantioselective syntheses of FR901464 and spliceostatin A, potent spliceosome inhibitors, are descr...
Efficient and selective total syntheses of spliceosome modulating natural products thailanstatins A...
ABSTRACT: An enantioselective total synthesis of spliceostatin E has been accomplished. The δ-lacton...
An enantioselective total synthesis of spliceostatin E has been accomplished. The δ-lactone unit A w...
Small molecule inhibitors that target components of the spliceosome have great potential as tools to...
An enantioselective total synthesis of spliceostatin E has been accomplished. The δ-lactone unit A w...
The spliceosome is a dynamic ribonucleo-protein complex that is in charge of removing introns from p...
Mining the genome sequence of <i>Burkholderia thailandensis</i> MSMB43 revealed a cryptic biosynthet...
Spliceostatin A is a potent inhibitor of spliceosomes and exhibits excellent anticancer activity aga...
Spliceostatin A is a potent inhibitor of spliceosomes and exhibits excellent anticancer activity aga...
Targeting the spliceosome with small molecule inhibitors provides a new avenue to target cancer by i...